Drug Research

AstraZeneca has agreed to acquire Boston-based Modella AI as drugmakers continue to increase their use of artificial intelligence to accelerate research and development. Financial terms of the deal were not disclosed. Modella AI said its foundation models and AI agents...

A number of regulatory changes have been released by the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to facilitate clinical research in the country. In order to expedite study approvals while maintaining patient safety, the UK clinical trial...

Teva Pharmaceutical Industries and Royalty Pharma have signed a funding agreement valued at up to $500 million to advance the development of TEV-408, an investigational therapy for autoimmune disorders, including vitiligo. The Teva, Royalty Pharma $500M deal would be...

An integrated partnership has been formed between Pierre Fabre Laboratories and Iktos to advance AI-driven oncology drug discovery. The collaboration focuses on identifying and developing new small-molecule drug candidates by combining Iktos’ AI and robotics technologies with Pierre Fabre’s...

Revvity, Inc. announced a collaboration with Eli Lilly and Company to broaden access to Lilly TuneLab by bringing the platform to the Revvity Signals ecosystem. The collaboration builds on Revvity’s recently launched Signals Xynthetica offering and aims to accelerate...

Amgen is going ahead and adding Dark Blue to its tapestry, embedding the preclinical blood cancer program of U.K. biotech into its organization. The California pharma has gone ahead and stitched together a deal of almost $840 million for Dark Blue Therapeutics, which is...

Shortly after going ahead and securing a partnership with Sanofi, InduPro is now linking up with Eli Lilly in its endeavors to discover novel cancer treatments through a pact that could as well be worth almost $950 million. InduPro is...